Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jörn Weisner

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Medchemcomm|August 29, 2018
Chemical modulation of transcription factorsBianca Wiedemann, Jörn Weisner, Daniel Rauh
Chemistry (Weinheim an Der Bergstrasse, Germany)|February 16, 2023
Insights into the Conformational Plasticity of the Protein Kinase Akt1 by Multi-Lateral Dipolar SpectroscopyJuliane Stehle, Jörn Weisner, Leanne Eichhorn, et al.
Chemical Communications (Cambridge, England)|August 5, 2020
Conformational selection vs. induced fit: insights into the binding mechanisms of p38α MAP Kinase inhibitorsPatrick Roser, Jörn Weisner, Juliane Stehle, et al.
Angewandte Chemie (International Ed. in English)|August 24, 2017
Covalent Lipid Pocket Ligands Targeting p38α MAPK MutantsMike Bührmann, Julia Hardick, Jörn Weisner, et al.
Chemical Communications (Cambridge, England)|October 9, 2018
Direct monitoring of the conformational equilibria of the activation loop in the mitogen-activated protein kinase p38αPatrick Roser, Jörn Weisner, Jeffrey R Simard, et al.
Journal of Medicinal Chemistry|April 9, 2024
Akt Inhibitor Advancements: From Capivasertib Approval to Covalent-Allosteric PromisesKosmas Alexandros Pervanidis, Giovanni Danilo D'Angelo, Jörn Weisner, et al.
Chemmedchem|August 7, 2018
RASPELD to Perform High-End Screening in an Academic Environment toward the Development of Cancer TherapeuticsPatrik Wolle, Jörn Weisner, Marina Keul, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|May 31, 2024
Synthesis of Asymmetric Ionic Hybrid Detergents enables Micelles with Scalable Properties including Cell CompatibilityVirginia Wycisk, Jan-Simon Behnke, Lena Nielinger, et al.
ACS Medicinal Chemistry Letters|May 14, 2025
Advancing TET Inhibitor Development: From Structural Insights to Biological EvaluationSuzanne Willems, Lejla Maksumic, Janina Niggenaber, et al.
Angewandte Chemie (International Ed. in English)|October 5, 2019
Covalent-Allosteric Inhibitors to Achieve Akt Isoform-SelectivityLena Quambusch, Ina Landel, Laura Depta, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Medchemcomm|August 29, 2018
Chemical modulation of transcription factorsBianca Wiedemann, Jörn Weisner, Daniel Rauh
Chemistry (Weinheim an Der Bergstrasse, Germany)|February 16, 2023
Insights into the Conformational Plasticity of the Protein Kinase Akt1 by Multi-Lateral Dipolar SpectroscopyJuliane Stehle, Jörn Weisner, Leanne Eichhorn, et al.
Chemical Communications (Cambridge, England)|August 5, 2020
Conformational selection vs. induced fit: insights into the binding mechanisms of p38α MAP Kinase inhibitorsPatrick Roser, Jörn Weisner, Juliane Stehle, et al.
Angewandte Chemie (International Ed. in English)|August 24, 2017
Covalent Lipid Pocket Ligands Targeting p38α MAPK MutantsMike Bührmann, Julia Hardick, Jörn Weisner, et al.
Chemical Communications (Cambridge, England)|October 9, 2018
Direct monitoring of the conformational equilibria of the activation loop in the mitogen-activated protein kinase p38αPatrick Roser, Jörn Weisner, Jeffrey R Simard, et al.
Journal of Medicinal Chemistry|April 9, 2024
Akt Inhibitor Advancements: From Capivasertib Approval to Covalent-Allosteric PromisesKosmas Alexandros Pervanidis, Giovanni Danilo D'Angelo, Jörn Weisner, et al.
Chemmedchem|August 7, 2018
RASPELD to Perform High-End Screening in an Academic Environment toward the Development of Cancer TherapeuticsPatrik Wolle, Jörn Weisner, Marina Keul, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|May 31, 2024
Synthesis of Asymmetric Ionic Hybrid Detergents enables Micelles with Scalable Properties including Cell CompatibilityVirginia Wycisk, Jan-Simon Behnke, Lena Nielinger, et al.
ACS Medicinal Chemistry Letters|May 14, 2025
Advancing TET Inhibitor Development: From Structural Insights to Biological EvaluationSuzanne Willems, Lejla Maksumic, Janina Niggenaber, et al.
Angewandte Chemie (International Ed. in English)|October 5, 2019
Covalent-Allosteric Inhibitors to Achieve Akt Isoform-SelectivityLena Quambusch, Ina Landel, Laura Depta, et al.
Pageof 3